©2024 Stanford Medicine
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Not Recruiting
Trial ID: NCT01860963
Purpose
This study is designed to establish the prevalence of anal squamous intraepithelial lesion
(ASIL) in patients with inflammatory bowel disease (IBD) and healthy controls.
Official Title
Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Eligibility
Inclusion Criteria:
- All IBD patients followed in the IBD clinic and healthy controls who are greater than
18 years old
Exclusion Criteria:
- History of HPV vaccination
- Pregnancy
- Other immunosuppressed states (i.e. systemic lupus erythematosus, rheumatoid
arthritis, cancer, Human Immunodeficiency Virus (HIV), transplant)
- IBD patients who don't meet immunosuppression/non-immunosuppression criteria
- Inability to obtain informed consent from patient
- Previous diagnosis of ASIL or anal/rectal cancer
Intervention(s):
procedure: Anal Pap smear and HPV DNA testing
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Shamita Shah, MD
650-736-0431